167 related articles for article (PubMed ID: 9421852)
1. Modulation of immune response by blood transfusion: evidence for a differential effect of allogeneic and autologous blood in colorectal cancer surgery.
Heiss MM; Fraunberger P; Delanoff C; Stets R; Allgayer H; Ströhlein MA; Tarabichi A; Faist E; Jauch KW; Schildberg FW
Shock; 1997 Dec; 8(6):402-8. PubMed ID: 9421852
[TBL] [Abstract][Full Text] [Related]
2. Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery.
Heiss MM; Mempel W; Delanoff C; Jauch KW; Gabka C; Mempel M; Dieterich HJ; Eissner HJ; Schildberg FW
J Clin Oncol; 1994 Sep; 12(9):1859-67. PubMed ID: 8083709
[TBL] [Abstract][Full Text] [Related]
3. Influence of autologous blood transfusion on natural killer and lymphokine-activated killer cell activities in cancer surgery.
Heiss MM; Fasol-Merten K; Allgayer H; Ströhlein MA; Tarabichi A; Wallner S; Eissner HI; Jauch KW; Schildberg FW
Vox Sang; 1997; 73(4):237-45. PubMed ID: 9407641
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic transfusion and infection: economic and clinical implications.
Blumberg N
Semin Hematol; 1997 Jul; 34(3 Suppl 2):34-40. PubMed ID: 9253782
[TBL] [Abstract][Full Text] [Related]
5. Blood transfusions and prognosis in colorectal cancer.
Busch OR; Hop WC; Hoynck van Papendrecht MA; Marquet RL; Jeekel J
N Engl J Med; 1993 May; 328(19):1372-6. PubMed ID: 8292113
[TBL] [Abstract][Full Text] [Related]
6. Impact of allogenic and autologous transfusion on immune function in patients with tumors.
Guo JR; Xu F; Jin XJ; Shen HC; Liu Y; Zhang YW; Shao Y
Asian Pac J Cancer Prev; 2014; 15(1):467-74. PubMed ID: 24528076
[TBL] [Abstract][Full Text] [Related]
7. Blood transfusions and prognosis in colorectal cancer: long-term results of a randomized controlled trial.
Harlaar JJ; Gosselink MP; Hop WC; Lange JF; Busch OR; Jeekel H
Ann Surg; 2012 Nov; 256(5):681-6; discussion 686-7. PubMed ID: 23095610
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulatory effects of allogeneic blood transfusions: clinical manifestations and mechanisms.
Blajchman MA
Vox Sang; 1998; 74 Suppl 2():315-9. PubMed ID: 9704462
[TBL] [Abstract][Full Text] [Related]
9. Postoperative inflammatory response after autologous and allogeneic blood transfusion.
Avall A; Hyllner M; Bengtson JP; Carlsson L; Bengtsson A
Anesthesiology; 1997 Sep; 87(3):511-6. PubMed ID: 9316954
[TBL] [Abstract][Full Text] [Related]
10. Blood transfusion with autologous and leukocyte-depleted or standard allogeneic red blood cells and the immune response to open heart surgery.
Perttilä JT; Salo MS; Jalonen JR; Kuttila KT; Viinamäki O; Pulkki KJ
Anesth Analg; 1994 Oct; 79(4):654-60. PubMed ID: 7943771
[TBL] [Abstract][Full Text] [Related]
11. Semi-allogeneic (F1) versus fully allogeneic blood transfusions: differences in their ability to induce specific immunological unresponsiveness.
Roelen DL; Dover EL; Niimi M; Young NT; Morris PJ; Wood KJ
Eur J Immunol; 1996 Jul; 26(7):1468-74. PubMed ID: 8766548
[TBL] [Abstract][Full Text] [Related]
12. Immunologic changes after transfusion of autologous or allogeneic buffy coat-poor versus WBC-reduced blood transfusions in patients undergoing arthroplasty. II. Activation of T cells, macrophages, and cell-mediated lympholysis.
Innerhofer P; Tilz G; Fuchs D; Luz G; Hobisch-Hagen P; Schobersberger W; Nussbaumer W; Lochs A; Irschick E
Transfusion; 2000 Jul; 40(7):821-7. PubMed ID: 10924610
[TBL] [Abstract][Full Text] [Related]
13. The effect of unmodified or prestorage white cell-reduced allogeneic red cell transfusions on the immune responsiveness in orthopedic surgery patients.
Bordin JO; Chiba AK; Carvalho KI; Takata ET; Falcão RP; Garcia AB; Bordin IA; Maciel MM; Andreoni S; Kerbauy J
Transfusion; 1999 Jul; 39(7):718-23. PubMed ID: 10413279
[TBL] [Abstract][Full Text] [Related]
14. The effect of blood transfusions on survival after surgery for colorectal cancer.
Busch OR; Hop WC; Marquet RL; Jeekel J
Eur J Cancer; 1995; 31A(7-8):1226-8. PubMed ID: 7577027
[TBL] [Abstract][Full Text] [Related]
15. Immunologic effects of allogeneic versus autologous blood transfusion in patients undergoing radical oesophagectomy.
Takemura M; Osugi H; Takada N; Kinoshita H; Higashino M
Eur Surg Res; 2003; 35(2):115-22. PubMed ID: 12679622
[TBL] [Abstract][Full Text] [Related]
16. [Clinical effects of blood transfusion-associated immune modulation on outcome of tumor surgery].
Heiss MM; Mempel W; Delanoff C; Mempel M; Jauch KW; Schildberg FW
Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():25-9. PubMed ID: 8374284
[TBL] [Abstract][Full Text] [Related]
17. Effect of perioperative allogeneic red blood cell transfusion on the immune-inflammatory response after colorectal cancer resection.
Ydy LR; Slhessarenko N; de Aguilar-Nascimento JE
World J Surg; 2007 Oct; 31(10):2044-51. PubMed ID: 17671807
[TBL] [Abstract][Full Text] [Related]
18. Transfusion practices among patients who did and did not predonate autologous blood before elective cardiac surgery.
Dupuis JY; Bart B; Bryson G; Robblee J
CMAJ; 1999 Apr; 160(7):997-1002. PubMed ID: 10207338
[TBL] [Abstract][Full Text] [Related]
19. Effect of autologous salvaged blood on postoperative natural killer cell precursor frequency.
Gharehbaghian A; Haque KM; Truman C; Evans R; Morse R; Newman J; Bannister G; Rogers C; Bradley BA
Lancet; 2004 Mar; 363(9414):1025-30. PubMed ID: 15051282
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic red blood cell transfusion is an independent risk factor for the development of postoperative bacterial infection.
Chang H; Hall GA; Geerts WH; Greenwood C; McLeod RS; Sher GD
Vox Sang; 2000; 78(1):13-8. PubMed ID: 10729806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
